Safety and pharmacokinetics of ODM-208 in patients with metastatic castration-resistant prostate cancer
Principal investigator: Utriainen Tapio
HUS Helsinki University Hospital, Comprehensive Cancer Center
Link to the ClinicalTrials.gov study website
